Last edition
News about "ONO Pharmaceutical "
Ono and Congruence to Generate Novel Small Molecule Correctors in Oncology Area
Under the terms of the agreement, Congruence will generate small molecule correctors by leveraging Congruence's proprietary drug discovery engine called, Revenir™.
Ono Pharmaceutical | 07/12/2024 | By Aishwarya
Ono Announces Acquisition of Deciphera Pharmaceuticals
Ono Pharmaceutical, Co., Ltd. has completed the tender offer to acquire all outstanding shares of common stock of a US biopharmaceutical company, Deciphera Pharmaceuticals, Inc. for USD 25.60 per share (total amount of approximately USD 2.4 billion) net to the seller in cash.
Ono Pharmaceutical | 14/06/2024 | By Aishwarya | 146
ONO to Acquire Deciphera Pharma for USD 2.4 Billion
Deciphera Pharmaceuticals, Inc. has signed a definitive merger agreement with ONO Pharmaceutical Co., Ltd. (ONO).
ONO Pharmaceutical | 30/04/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy